Male Oncology Research and Education program for men at high risk for prostate cancer.

about

"Guys Don't Have Breasts": The Lived Experience of Men Who Have BRCA Gene Mutations and Are at Risk for Male Breast Cancer.

P2860

Q50200924-CEC310A8-513E-4250-B109-04C9F28C416B

P2860

Male Oncology Research and Education program for men at high risk for prostate cancer.

Item

http://www.wikidata.org/entity/Q55249860

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Male Oncology Research and Education program for men at high risk for prostate cancer.

@en

Male Oncology Research and Education program for men at high risk for prostate cancer.

@nl

type

Item

label

Male Oncology Research and Education program for men at high risk for prostate cancer.

@en

Male Oncology Research and Education program for men at high risk for prostate cancer.

@nl

prefLabel

Male Oncology Research and Education program for men at high risk for prostate cancer.

@en

Male Oncology Research and Education program for men at high risk for prostate cancer.

@nl

P1476

Male Oncology Research and Education program for men at high risk for prostate cancer

@en

P2093

D Vesprini

http://www.w3.org/2001/XMLSchema#string

J Lorentz

http://www.w3.org/2001/XMLSchema#string

P2860

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.

Nutrition, dietary interventions and prostate cancer: the latest evidence

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Early detection of prostate cancer: AUA Guideline.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.

BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

P304

170-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.25.3818

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stanley K Liu

P577

2018-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29719433

http://www.w3.org/2001/XMLSchema#string

P932

5927788

http://www.w3.org/2001/XMLSchema#string

Male Oncology Research and Education program for men at high risk for prostate cancer.

about

P2860

P2860

Male Oncology Research and Education program for men at high risk for prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932